SCHEMBL7702338

SCHEMBL7702338

CCOC(=O)C1=Cc2cccc(S(=O)(=O)N3CCOCC3)c2OC=C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 4/20 0.44
USP2 O75604 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HSD17B10 Q99714 3/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 2/20 0.44
MITF O75030 1/20 0.44
NTSR1 P30989 1/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 3/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.40
CREBBP Q92793 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702331 0.79 ALDH1A1 (0.45) TSHRALDH1A1MAPK1USP2SMN1; SMN2
SCHEMBL3997775 0.65 ALDH1A1 (0.64) TSHRALDH1A1MAPK1USP2SMN1; SMN2
SCHEMBL3996272 0.65 TSHR (0.59) TSHRALDH1A1MAPK1USP2SMN1; SMN2
SCHEMBL3996318 0.64 ALDH1A1 (0.55) TSHRALDH1A1MAPK1USP2SMN1; SMN2
SCHEMBL7697790 0.63 ALDH1A1 (0.35) TSHRALDH1A1MAPK1USP2SMN1; SMN2
SCHEMBL14697013 0.63 HSD17B10 (0.56) ALDH1A1HSD17B10LMNAGAA
SCHEMBL11174072 0.63 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TP53KMT2ALMNA
SCHEMBL16891569 0.63 NPC1 (0.52) TSHRALDH1A1USP2SMN1; SMN2KMT2A
SCHEMBL15936325 0.63 ALDH1A1 (0.50) TSHRALDH1A1HSD17B10KMT2ALMNA
SCHEMBL1911955 0.62 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed